These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 17668956)

  • 1. The University of Pennsylvania/Walter Reed Army Medical Center proton therapy program.
    McDonough J; Tinnel B
    Technol Cancer Res Treat; 2007 Aug; 6(4 Suppl):73-6. PubMed ID: 17668956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The M. D. Anderson proton therapy system.
    Smith A; Gillin M; Bues M; Zhu XR; Suzuki K; Mohan R; Woo S; Lee A; Komaki R; Cox J; Hiramoto K; Akiyama H; Ishida T; Sasaki T; Matsuda K
    Med Phys; 2009 Sep; 36(9):4068-83. PubMed ID: 19810479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analytical shielding calculations for a proton therapy facility.
    Avery S; Ainsley C; Maughan R; McDonough J
    Radiat Prot Dosimetry; 2008; 131(2):167-79. PubMed ID: 18487617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving proton therapy accessibility through seamless electronic integration of remote treatment planning sites.
    Belard A; Dolney D; Zelig T; McDonough J; O'Connell J
    Telemed J E Health; 2011 Jun; 17(5):370-5. PubMed ID: 21492029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical proton radiation therapy research at the Francis H. Burr Proton Therapy Center.
    DeLaney TF
    Technol Cancer Res Treat; 2007 Aug; 6(4 Suppl):61-6. PubMed ID: 17668954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo verification of proton beam path by using post-treatment PET/CT imaging.
    Hsi WC; Indelicato DJ; Vargas C; Duvvuri S; Li Z; Palta J
    Med Phys; 2009 Sep; 36(9):4136-46. PubMed ID: 19810487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photon and proton therapy planning comparison for malignant glioma based on CT, FDG-PET, DTI-MRI and fiber tracking.
    Munck Af Rosenschöld P; Engelholm S; Ohlhues L; Law I; Vogelius I; Engelholm SA
    Acta Oncol; 2011 Aug; 50(6):777-83. PubMed ID: 21767174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment planning for conformal proton radiation therapy.
    Bussière MR; Adams JA
    Technol Cancer Res Treat; 2003 Oct; 2(5):389-99. PubMed ID: 14529304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The development and clinical use of a beam ON-LINE PET system mounted on a rotating gantry port in proton therapy.
    Nishio T; Miyatake A; Ogino T; Nakagawa K; Saijo N; Esumi H
    Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):277-86. PubMed ID: 20005459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The National Center for Oncological Hadron Therapy: status of the project and future clinical use of the facility.
    Orecchia R; Fossati P; Rossi S
    Tumori; 2009; 95(2):169-76. PubMed ID: 19579862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vision 20/20: proton therapy.
    Smith AR
    Med Phys; 2009 Feb; 36(2):556-68. PubMed ID: 19291995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton beam radiotherapy versus fractionated stereotactic radiotherapy for uveal melanomas: A comparative study.
    Weber DC; Bogner J; Verwey J; Georg D; Dieckmann K; Escudé L; Caro M; Pötter R; Goitein G; Lomax AJ; Miralbell R
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):373-84. PubMed ID: 16168832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and operation of the Loma Linda University Medical Center proton facility.
    Slater JD
    Technol Cancer Res Treat; 2007 Aug; 6(4 Suppl):67-72. PubMed ID: 17668955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy systems using proton and carbon beams.
    Jongen Y
    Bull Mem Acad R Med Belg; 2008; 163(10-12):471-8; discussion 479-80. PubMed ID: 20120253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton Therapy Facility Planning From a Clinical and Operational Model.
    Das IJ; Moskvin VP; Zhao Q; Cheng CW; Johnstone PA
    Technol Cancer Res Treat; 2015 Oct; 14(5):635-41. PubMed ID: 24988058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose to normal tissues outside the radiation therapy patient's treated volume: a review of different radiation therapy techniques.
    Purdy JA
    Health Phys; 2008 Nov; 95(5):666-76. PubMed ID: 18849701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Facility overview for a proton beam treatment center.
    Lesyna D
    Technol Cancer Res Treat; 2007 Aug; 6(4 Suppl):41-8. PubMed ID: 17668951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.
    Suit H; Kooy H; Trofimov A; Farr J; Munzenrider J; DeLaney T; Loeffler J; Clasie B; Safai S; Paganetti H
    Radiother Oncol; 2008 Feb; 86(2):148-53. PubMed ID: 18237800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monte Carlo patient study on the comparison of prompt gamma and PET imaging for range verification in proton therapy.
    Moteabbed M; España S; Paganetti H
    Phys Med Biol; 2011 Feb; 56(4):1063-82. PubMed ID: 21263174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose conformation of intensity-modulated stereotactic photon beams, proton beams, and intensity-modulated proton beams for intracranial lesions.
    Baumert BG; Norton IA; Lomax AJ; Davis JB
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1314-24. PubMed ID: 15519805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.